Discontinued Operations, Sale of Clinical Labs Business (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jul. 24, 2023 |
Jul. 31, 2024 |
Jul. 31, 2023 |
|
| Discontinued Operations, Sale of Clinical Labs Business [Line Items] | |||
| Right of use asset impairment charge | $ 3,900 | ||
| Other expense | 7,700 | $ 6,216 | |
| Cash used in operation activities | 14,972 | 19,000 | |
| Cash used in investing activities | 0 | $ 101,300 | |
| Enzo Clinical Labs [Member] | |||
| Discontinued Operations, Sale of Clinical Labs Business [Line Items] | |||
| Aggregate purchase price | $ 113,250 | ||
| Transaction costs | 9,941 | ||
| Transaction fees and related closing costs | 7,238 | ||
| Performance bonuses | $ 2,703 | ||
| X | ||||||||||
- Definition Represents the amount of aggregate purchase price on discontinued operation. No definition available.
|
| X | ||||||||||
- Definition Amount classified as right of use assets attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition The amount of transaction costs. No definition available.
|
| X | ||||||||||
- Definition The amount of transaction fees and related closing costs. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|